Semaglutide leads to greater weight loss in women than men with heart failure, improves symptoms retrieved 24 June 2024 from https://medicalxpress.com/news/2024-06-semaglutide-greater-weight-loss-women.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.May 30, 2024Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart diseaseA recent study in Nature Medicine shows semaglutide reduces kidney risks in non-diabetic obese patients with cardiovascular disease by 22%. The SELECT trial results highlight semaglutide's benefits for kidney function and overall cardiovascular health.
Source: NewsMedical - 🏆 19. / 71 Read more »
Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).
Source: NewsMedical - 🏆 19. / 71 Read more »
Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch studyA recent study from the PIONEER REAL Netherlands trial demonstrated that oral semaglutide effectively manages type 2 diabetes and supports weight loss in adults.
Source: NewsMedical - 🏆 19. / 71 Read more »
Study finds semaglutide associated with reduction in incidence and recurrence of alcohol-use disorderA new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.
Source: medical_xpress - 🏆 101. / 51 Read more »
Oral semaglutide shows significant promise in improving diabetes control and cardiovascular health, study revealsA recent study in the Journal of Clinical Medicine found that oral semaglutide significantly improves glycemic control and reduces body weight in type 2 diabetes patients after 24 weeks of treatment.
Source: NewsMedical - 🏆 19. / 71 Read more »
Oral semaglutide shows promising results for type 2 diabetes in routine clinical settingsSemaglutide and its effects on glycemic control, body weight (BW), and tolerability in routine clinical practice.
Source: NewsMedical - 🏆 19. / 71 Read more »